Seoulin Bioscience Co.,Ltd. (KOSDAQ:038070)
South Korea · Delayed Price · Currency is KRW 4,055.00
-75.00 (-1.82%)
At close: Sep 11, 2026
Seoulin Bioscience Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 9,318 | 10,452 | 8,949 | 14,602 | 8,999 | 14,973 |
Short-Term Investments | 18,866 | 22,256 | 14,467 | 20,722 | 41,319 | 40,360 |
Trading Asset Securities | 2,027 | 2,008 | 93.22 | 90.3 | 4,962 | 19,999 |
Cash & Short-Term Investments | 30,211 | 34,716 | 23,510 | 35,414 | 55,280 | 75,332 |
Cash Growth | 5.62% | 47.67% | -33.62% | -35.94% | -26.62% | 279.32% |
Accounts Receivable | 7,083 | 8,121 | 7,323 | 12,986 | 6,652 | 10,137 |
Other Receivables | 203.04 | 408.81 | 528.24 | 1,291 | 630.36 | 196.33 |
Receivables | 7,286 | 8,529 | 7,851 | 14,294 | 7,282 | 10,333 |
Inventory | 25,546 | 24,721 | 26,245 | 21,785 | 17,307 | 13,933 |
Prepaid Expenses | 91.93 | 33.28 | 13.63 | 53.74 | 51.32 | 32.59 |
Other Current Assets | 5,308 | 4,035 | 2,222 | 1,408 | 7,366 | 5,352 |
Total Current Assets | 68,444 | 72,035 | 59,841 | 72,955 | 87,287 | 104,983 |
Property, Plant & Equipment | 17,037 | 16,839 | 16,628 | 18,914 | 16,491 | 14,937 |
Long-Term Investments | 25,065 | 24,928 | 19,460 | 17,512 | 25,555 | 7,515 |
Goodwill | - | - | 373.89 | 526.49 | 526.49 | 526.49 |
Other Intangible Assets | 338.71 | 359.98 | 395.06 | 425.08 | 266.64 | 230.54 |
Long-Term Deferred Tax Assets | 2,052 | 2,098 | 2,222 | 2,259 | 1,269 | 2,766 |
Long-Term Deferred Charges | 50.57 | 69.65 | 107.82 | 156.08 | 210.96 | 558.01 |
Other Long-Term Assets | 2,254 | 2,469 | 2,496 | 1,335 | 3,840 | 5,051 |
Total Assets | 115,241 | 118,798 | 101,525 | 114,100 | 135,486 | 136,566 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 6,570 | 7,543 | 5,009 | 11,428 | 8,603 | 10,888 |
Accrued Expenses | 632.34 | 477.01 | 390.22 | 387.97 | 373.05 | 329.11 |
Short-Term Debt | 9,948 | 11,422 | 3,450 | 6,120 | 17,469 | 15,259 |
Current Portion of Long-Term Debt | - | - | - | - | 62.5 | 256.25 |
Current Portion of Leases | 213.28 | 95.56 | 156.68 | 271.44 | 69.22 | 34.65 |
Current Income Taxes Payable | - | - | - | 700.11 | 730.13 | 4,561 |
Other Current Liabilities | 7,677 | 12,132 | 4,628 | 9,122 | 19,058 | 28,112 |
Total Current Liabilities | 25,041 | 31,669 | 13,634 | 28,030 | 46,365 | 59,440 |
Long-Term Debt | 2,940 | - | - | 98.6 | 98.47 | 154.85 |
Long-Term Leases | 177.91 | 62.61 | 73.29 | 224.29 | 86.11 | 32.85 |
Pension & Post-Retirement Benefits | 984.79 | 537.63 | 478.96 | 254.11 | - | 285.87 |
Other Long-Term Liabilities | 467.2 | 476.95 | 465.66 | 253.48 | 151.59 | 150 |
Total Liabilities | 29,611 | 32,746 | 14,652 | 28,861 | 46,701 | 60,064 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 4,650 | 4,550 | 4,450 | 4,350 | 4,250 | 4,150 |
Additional Paid-In Capital | 18,921 | 18,921 | 18,519 | 18,519 | 18,519 | 18,490 |
Retained Earnings | 68,633 | 69,090 | 69,170 | 67,177 | 68,475 | 58,805 |
Treasury Stock | -4,607 | -4,555 | -4,496 | -3,404 | -3,261 | -3,062 |
Comprehensive Income & Other | -3,795 | -3,795 | -3,751 | -3,581 | -3,581 | -3,523 |
Total Common Equity | 83,801 | 84,211 | 83,893 | 83,063 | 84,403 | 74,861 |
Minority Interest | 1,829 | 1,841 | 2,980 | 2,177 | 4,382 | 1,642 |
Shareholders' Equity | 85,631 | 86,052 | 86,872 | 85,239 | 88,785 | 76,502 |
Total Liabilities & Equity | 115,241 | 118,798 | 101,525 | 114,100 | 135,486 | 136,566 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 13,279 | 11,580 | 3,680 | 6,714 | 17,785 | 15,738 |
Net Cash (Debt) | 16,932 | 23,137 | 19,830 | 28,700 | 37,495 | 59,594 |
Net Cash Growth | -13.51% | 16.68% | -30.91% | -23.46% | -37.08% | 211.92% |
Net Cash Per Share | 1971.91 | 2400.48 | 2279.74 | 3201.94 | 3369.03 | 6625.03 |
Filing Date Shares Outstanding | 8.82 | 8.63 | 8.63 | 8.76 | 8.77 | 8.77 |
Total Common Shares Outstanding | 8.82 | 8.63 | 8.96 | 8.97 | 8.98 | 8.99 |
Working Capital | 43,403 | 40,366 | 46,207 | 44,924 | 40,922 | 45,543 |
Book Value Per Share | 9502.68 | 9761.49 | 9363.40 | 9262.33 | 9398.97 | 8324.26 |
Tangible Book Value | 83,463 | 83,851 | 83,124 | 82,111 | 83,610 | 74,104 |
Tangible Book Value Per Share | 9464.28 | 9719.76 | 9277.57 | 9156.22 | 9310.65 | 8240.08 |
Land | 4,074 | 4,074 | 3,967 | 4,246 | 3,721 | 3,185 |
Buildings | 11,023 | 11,204 | 11,263 | 12,539 | 11,192 | 10,642 |
Machinery | 1,447 | 1,281 | 1,026 | 1,474 | 1,193 | 851.95 |
Construction In Progress | - | - | - | - | 6 | - |